about
Nilotinib counteracts P-glycoprotein-mediated multidrug resistance and synergizes the antitumoral effect of doxorubicin in soft tissue sarcomasInhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4',5':4,5]thieno(2,3-b)quinolineExpression and purification of Src-family kinases for solution NMR studies.Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas.
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Tyrosine kinase inhibitors as cancer therapy.
@ast
Tyrosine kinase inhibitors as cancer therapy.
@en
type
label
Tyrosine kinase inhibitors as cancer therapy.
@ast
Tyrosine kinase inhibitors as cancer therapy.
@en
prefLabel
Tyrosine kinase inhibitors as cancer therapy.
@ast
Tyrosine kinase inhibitors as cancer therapy.
@en
P2860
P356
P1433
P1476
Tyrosine kinase inhibitors as cancer therapy.
@en
P2093
Gwen L Nichols
P2860
P304
P356
10.1081/CNV-120023774
P577
2003-01-01T00:00:00Z